26542804|t|The Voltage-dependent Anion Channel 1 Mediates Amyloid beta Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
26542804|a|The voltage-dependent anion channel 1 (VDAC1), found in the mitochondrial outer membrane, forms the main interface between mitochondrial and cellular metabolisms, mediates the passage of a variety of molecules across the mitochondrial outer membrane, and is central to mitochondria-mediated apoptosis. VDAC1 is overexpressed in post-mortem brains of Alzheimer disease (AD) patients. The development and progress of AD are associated with mitochondrial dysfunction resulting from the cytotoxic effects of accumulated amyloid beta (Abeta). In this study we demonstrate the involvement of VDAC1 and a VDAC1 N-terminal peptide (VDAC1-N-Ter) in Abeta cell penetration and cell death induction. Abeta directly interacted with VDAC1 and VDAC1-N-Ter, as monitored by VDAC1 channel conductance, surface plasmon resonance, and microscale thermophoresis. Preincubated Abeta interacted with bilayer-reconstituted VDAC1 and increased its conductance ~ 2-fold. Incubation of cells with Abeta resulted in mitochondria-mediated apoptotic cell death. However, the presence of non-cell-penetrating VDAC1-N-Ter peptide prevented Abeta cellular entry and Abeta-induced mitochondria-mediated apoptosis. Likewise, silencing VDAC1 expression by specific siRNA prevented Abeta entry into the cytosol as well as Abeta-induced toxicity. Finally, the mode of Abeta-mediated action involves detachment of mitochondria-bound hexokinase, induction of VDAC1 oligomerization, and cytochrome c release, a sequence of events leading to apoptosis. As such, we suggest that Abeta-mediated toxicity involves mitochondrial and plasma membrane VDAC1, leading to mitochondrial dysfunction and apoptosis induction. The VDAC1-N-Ter peptide targeting Abeta cytotoxicity is thus a potential new therapeutic strategy for AD treatment.
26542804	4	37	Voltage-dependent Anion Channel 1	Gene	7416
26542804	47	59	Amyloid beta	Gene	351
26542804	60	68	Toxicity	Disease	MESH:D064420
26542804	107	124	Alzheimer Disease	Disease	MESH:D000544
26542804	138	171	voltage-dependent anion channel 1	Gene	7416
26542804	173	178	VDAC1	Gene	7416
26542804	436	441	VDAC1	Gene	7416
26542804	484	501	Alzheimer disease	Disease	MESH:D000544
26542804	503	505	AD	Disease	MESH:D000544
26542804	507	515	patients	Species	9606
26542804	549	551	AD	Disease	MESH:D000544
26542804	572	597	mitochondrial dysfunction	Disease	MESH:D028361
26542804	650	662	amyloid beta	Gene	351
26542804	664	669	Abeta	Gene	351
26542804	720	725	VDAC1	Gene	7416
26542804	732	737	VDAC1	Gene	7416
26542804	758	763	VDAC1	Gene	7416
26542804	774	779	Abeta	Gene	351
26542804	823	828	Abeta	Gene	351
26542804	854	859	VDAC1	Gene	7416
26542804	864	869	VDAC1	Gene	7416
26542804	893	898	VDAC1	Gene	7416
26542804	991	996	Abeta	Gene	351
26542804	1035	1040	VDAC1	Gene	7416
26542804	1106	1111	Abeta	Gene	351
26542804	1244	1249	Abeta	Gene	351
26542804	1269	1274	Abeta	Gene	351
26542804	1336	1341	VDAC1	Gene	7416
26542804	1381	1386	Abeta	Gene	351
26542804	1421	1426	Abeta	Gene	351
26542804	1435	1443	toxicity	Disease	MESH:D064420
26542804	1466	1471	Abeta	Gene	351
26542804	1530	1540	hexokinase	Gene	3098
26542804	1555	1560	VDAC1	Gene	7416
26542804	1582	1594	cytochrome c	Gene	54205
26542804	1672	1677	Abeta	Gene	351
26542804	1687	1695	toxicity	Disease	MESH:D064420
26542804	1739	1744	VDAC1	Gene	7416
26542804	1757	1782	mitochondrial dysfunction	Disease	MESH:D028361
26542804	1842	1847	Abeta	Gene	351
26542804	1848	1860	cytotoxicity	Disease	MESH:D064420
26542804	1910	1912	AD	Disease	MESH:D000544
26542804	Association	MESH:D000544	351
26542804	Positive_Correlation	MESH:D028361	351
26542804	Association	MESH:D064420	7416
26542804	Association	3098	351
26542804	Association	351	54205
26542804	Positive_Correlation	MESH:D000544	7416
26542804	Positive_Correlation	MESH:D064420	351
26542804	Association	351	7416

